Showing results (1931-1940 of 6,771) with videos related to

Sort By:
Pageof 678
Clinical Therapeutics|January 1, 1986
Comparison of diflunisal and acetaminophen with codeine in the treatment of initial or recurrent acute low back strainF L Brown, S Bodison, J Dixon, et al.
Clinical Therapeutics|December 27, 2017
Aerobic Exercise as an Adjuvant to Aphasia Therapy: Theory, Preliminary Findings, and Future DirectionsStacy M Harnish, Amy D Rodriguez, Deena Schwen Blackett, et al.
Clinical Therapeutics|December 28, 2020
Dose Optimization of Vancomycin Using a Mechanism-based Exposure-Response Model in Pediatric Infectious Disease PatientsWoo Jin Jung, Jung-Hyuck Park, Sungwoo Goo, et al.
Clinical Therapeutics|January 1, 1986
Midodrine for female incontinence: a preliminary reportF Garofalo, G M Lalanne, G Nanni
Clinical Therapeutics|October 1, 2013
Bortezomib subcutaneous injection in combination regimens for myeloma or systemic light-chain amyloidosis: a retrospective chart review of response rates and toxicity in newly diagnosed patientsGunjan Shah, Esha Kaul, Shelly Fallo, et al.
Clinical Therapeutics|January 1, 2014
Dapagliflozin as monotherapy in drug-naive Asian patients with type 2 diabetes mellitus: a randomized, blinded, prospective phase III studyLinong Ji, Jianhua Ma, Hongmei Li, et al.
Clinical Therapeutics|January 1, 2014
Comparison of the pharmacokinetics, safety, and tolerability of vitamin D3 in DP-R206 (150-mg ibandronate/24,000-IU vitamin D3 tablet) and as monotherapy (24,000 iu) in healthy male Korean adultsJi-Young Jeon, Sun Young Lee, Yong-Jin Im, et al.
Clinical Therapeutics|December 27, 2021
Industry Sponsor Influence in Clinical Trial Reporting in Canada: A Qualitative Interview StudyRichard L Morrow, Barbara Mintzes, Garry Gray, et al.
Clinical Therapeutics|February 9, 2021
A Survey of Practices in the United States Regarding Hepatitis C Screening in Pregnant WomenElizabeth A Godar, Ravi Jhaveri
Clinical Therapeutics|November 25, 2018
Clopidogrel Versus Aspirin for the Treatment of Acute Coronary Syndrome After a 12-Month Dual Antiplatelet Therapy: A Cost-effectiveness Analysis From China Payer's PerspectiveLei Zhang, Ziyi Lin, Hongjun Yin, et al.
Pageof 678